News For BSX From The Last 14 Days Check below for free stories on BSX the last two weeks.
There are 6 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 2, 2010
|
| 08:36 EDT |  | BSX |
|
|
February 1, 2010
|
| 20:35 EDT |  | BSX |
| | 11:00 EDT |  | BSX |
| | 10:36 EDT | | BSX |
| | 10:00 EDT | | BSX |
| theflyonthewall.com: | Boston Scientific shares likely to be weak following settlement, says Leerink | | Leerink expects Boston Scientific (BSX) shares to be weak on news of the company's settlement with Johnson & Johnson (JNJ) given the size of the deal and balance sheet pressures involved. However, the firm points out the settlement resolves most of Boston Scientific's major litigation risks. :theflyonthewall.com |
| | 08:03 EDT | | BSX |
| theflyonthewall.com: | Boston Scientific settles patent disputes with Johnson & Johnson | | Boston Scientific Corporation (BSX) announced the settlement of three patent disputes with Johnson & Johnson (JNJ). The disputes date back to 2003 and cover Boston Scientific's Jang patent and J&J's Palmaz and Gray patents, all of which involve intellectual property in the cardiovascular arena. Boston Scientific will make a $1.725B payment to J&J in connection with the settlement. Under the settlement, Boston Scientific will pay J&J $1B today and the balance on or before the first week of January 2011. The Company plans to post a $745M letter of credit, which will cover the $725M balance and interest. The payments will not have an appreciable impact on the Company's debt covenants. After the payments, the Company will still have significant liquidity under its credit facilities, and it continues to expect to refinance its 2011 debt maturities in the middle of this year. The Company expects to fund the $725M remaining balance from cash on hand, unless it refinances at an earlier date. :theflyonthewall.com |
|
|
|
Subscribe for More Information